[MDGL] YoY Annual Result on 31-Dec-2013 [#FY]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
11-Mar-2014
Financial Year
2013
Quarter
31-Dec-2013 [#FY]
Profit Trend
YoY- -43.64%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Annual Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 0 0 0 0 147 7,584 14,803 -
PBT -26,388 -68,671 -86,161 -90,192 -62,790 -47,380 -37,467 -5.67%
Tax -0 0 0 0 0 0 0 -
NP -26,388 -68,671 -86,161 -90,192 -62,790 -47,380 -37,467 -5.67%
Tax Rate - - - - - - - -
Total Cost 26,388 68,671 86,161 90,192 62,937 54,964 52,270 -10.75%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin 0.00 0.00 0.00 0.00 -42,714.29 -624.74 -253.10 -
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
EPS -5.07 -401.56 -30.62 -44.48 -36.99 -35.14 -32.49 -26.60%
EPS Diluted -5.07 -401.56 -30.62 -44.48 -36.99 -35.14 -32.49 -26.60%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.